Marijuana Rated Most Effective for Treating Fibromyalgia

marijuana graph

“Medical marijuana is far more effective at treating symptoms of fibromyalgia than any of the three prescription drugs approved by the Food and Drug Administration to treat the disorder.

That is one of the surprise findings in an online survey of over 1,300 fibromyalgia patients conducted by the National Pain Foundation and National Pain Report.”

Cymbalta graph

Lyrica graph

Savella graph.”

“The FDA has approved only three drugs – Cymbalta, Lyrica and Savella — for the treatment of fibromyalgia.”

http://americannewsreport.com/nationalpainreport/marijuana-rated-most-effective-for-treating-fibromyalgia-8823638.html

http://www.thctotalhealthcare.com/category/fibromyalgia/

 

Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.

“Cannabis sativa L. has been utilized for treatment of pain and sleep disorders since ancient times.

This review examines modern studies on effects of Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on sleep. It goes on to report new information on the effects on sleep in the context of medical treatment of neuropathic pain and symptoms of multiple sclerosis, employing standardized oromucosal cannabis-based medicines containing primarily THC, CBD, or a 1 : 1 combination of the two (Sativex).

Sleep-laboratory results indicate a mild activating effect of CBD, and slight residual sedation with THC-predominant extracts. Experience to date with Sativex in numerous Phase I-III studies in 2000 subjects with 1000 patient years of exposure demonstrate marked improvement in subjective sleep parameters in patients with a wide variety of pain conditions including multiple sclerosis, peripheral neuropathic pain, intractable cancer pain, and rheumatoid arthritis, with an acceptable adverse event profile.

No tolerance to the benefit of Sativex on pain or sleep, nor need for dosage increases have been noted in safety extension studies of up to four years, wherein 40-50% of subjects attained good or very good sleep quality, a key source of disability in chronic pain syndromes that may contribute to patients’ quality of life.”

http://www.ncbi.nlm.nih.gov/pubmed/17712817

Miracle Drug: Medical Marijuana Cures Child of Terminal Epilepsy

Mia Wilkinson

“Only until recently has medical marijuana received its deserved accolades by the mainstream media as a miracle drug; however, many in the medical industry are still leaving pot on the back-burner….until NOW.

A Canadian mother named Sarah Wilkinson has tangible claims about how cannabis has saved her disabled and once terminally ill daughter’s life.”

During an interview with the Toronto Sun, Wilkinson said “I assumed people who wanted it just wanted to get high” prior to her daughter’s marijuana use. However, once administering marijuana to her daughter with no other options from the pharmaceutical industry, Mia’s seizures went from 100 a day to 8 at most, changing her stance about the drug overnight. Results upon using the herb were immediate. Mia’s seizures ended within 24 hours of using the herb and now the Wilkinson’s don’t hesitate to call the drug a miracle.”

http://www.prweb.com/releases/2014/05/prweb11808330.htm

“Medical marijuana gives epileptic child new lease on life”  http://www.torontosun.com/2014/04/26/medical-marijuana-gives-epileptic-child-new-lease-on-life

“Medical Marijuana Helps Epileptic Child Suffering 100 Seizures a Day”  http://www.ibtimes.co.uk/medical-marijuana-helps-epileptic-child-suffering-100-seizures-day-1446463

“Marijuana Miracle: Epileptic Child Who Suffered 100 Seizures Daily ‘Gets Cured’ After Using the Herb”  http://au.ibtimes.com/articles/549768/20140428/marijuana-miracle-health-benefits-epilepsy-child-seizure.htm#.U2JQLehX-uY

http://www.thctotalhealthcare.com/category/epilepsy-2/

Therapeutic benefits of cannabis: a patient survey.

“Clinical research regarding the therapeutic benefits of cannabis (“marijuana”) has been almost non-existent in the United States since cannabis was given Schedule I status in the Controlled Substances Act of 1970.

In order to discover the benefits and adverse effects perceived by medical cannabis patients, especially with regards to chronic pain, we hand-delivered surveys to one hundred consecutive patients who were returning for yearly re-certification for medical cannabis use in Hawai’i. The response rate was 94%. Mean and median ages were 49.3 and 51 years respectively. Ninety-seven per cent of respondents used cannabis primarily for chronic pain. Average pain improvement on a 0-10 pain scale was 5.0 (from 7.8 to 2.8), which translates to a 64% relative decrease in average pain. Half of all respondents also noted relief from stress/anxiety, and nearly half (45%) reported relief from insomnia. Most patients (71%) reported no adverse effects, while 6% reported a cough or throat irritation and 5% feared arrest even though medical cannabis is legal in Hawai’i.

No serious adverse effects were reported.

These results suggest that Cannabis is an extremely safe and effective medication for many chronic pain patients. Cannabis appears to alleviate pain, insomnia, and may be helpful in relieving anxiety.

Cannabis has shown extreme promise in the treatment of numerous medical problems and deserves to be released from the current Schedule I federal prohibition against research and prescription.”

http://www.ncbi.nlm.nih.gov/pubmed/24765558

Full text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/

It’s Easier To Die from Drinking Too Much Water Than Smoking Too Much Pot

THC-3D-(with-cannabis-leaf-bkg)

“In February, reports filtered in from Germany that two men died of cardiac arrhythmia triggered by marijuana intoxication. At a headline’s glance, the tragic deaths seemed to spoil cannabis’ unblemished track record: Until that point, no cases of fatal overdose were known to science.

It should be noted, however, that these two men — aged 23 and 28 — did not overdose. The researchers who reviewed their deaths in the journal Forensic Science International reported found that “the younger man had a serious undetected heart problem and the older one had a history of alcohol, amphetamine and cocaine abuse.” Since all other causes of death were ruled out, the researchers assumed that marijuana spiked their heart rates and blood pressures, causing their hearts to fall out of rhythm.

In the absence of underlying health conditions, it is practically impossible to die from smoking marijuana. The LD50 — the dose required to kill half the subjects in a test population — of marijuana’s active chemical THC is somewhere between 15 and 70 grams for the average human. As the University of Michigan’s Mind the Science Gap described, that’s “absurdly high”:

“To put that in perspective, the casual user (once a month or so) generally only needs about 2-3 mg of THC to become intoxicated, while habitual users might need between five and ten times that amount. Since 3 mg = 0.003 g, a casual user would need to smoke about 5000 times their normal amount to approach a potentially lethal dose.””

 

What chemicals are deadlier than THC? Quite a few actually. Cyanide, arsenic, and strychnine obviously top THC, but so does nicotine, caffeine, ethanol, and table salt! A convincing case can even be made that it’s easier to overdose on the very essence of life on Earth: water.

Though water has a vastly higher LD50 compared to any other chemical — roughly 90 grams per kilogram of body weight — humans are surprisingly able to slurp down too much of it, especially when competition, peer pressure, exercise, or the drug ecstasy are involved.

In 2007, a California woman died from water intoxication after drinking six liters of water — roughly 25 glasses — in three hours. Writing in Scientific American, Coco Ballantyne recounted other noted deaths and issues associated with excessive water intake:

 

In 2005 a fraternity hazing at California State University, Chico, left a 21-year-old man dead after he was forced to drink excessive amounts of water between rounds of push-ups in a cold basement. Club-goers taking MDMA (“ecstasy”) have died after consuming copious amounts of water trying to rehydrate following long nights of dancing and sweating. Going overboard in attempts to rehydrate is also common among endurance athletes. A 2005 study in the New England Journal of Medicine found that close to one sixth of marathon runners develop some degree of hyponatremia, or dilution of the blood caused by drinking too much water.

 

Water, of course, is easier to access than marijuana. If THC ubiquitously flowed from taps and showerheads, doubtless somebody would have found a way to overdose. As it is, you’d be hard pressed to find an average person with enough marijuana to kill himself. Thus, water’s body count remains higher.”

 

http://www.forbes.com/sites/rosspomeroy/2014/04/24/its-easier-to-die-from-drinking-too-much-water-than-smoking-too-much-pot/

Getting High on the Endocannabinoid System

“The endogenous cannabinoid system—named for the plant that led to its discovery—is one of the most important physiologic systems involved in establishing and maintaining human health.

Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. With its complex actions in our immune system, nervous system, and virtually all of the body’s organs, the endocannabinoids are literally a bridge between body and mind.

By understanding this system, we begin to see a mechanism that could connect brain activity and states of physical health and disease.

…either stimulating or inhibiting the endocannabinoid system could have beneficial effects.

The most direct route of THC administration is by smoking marijuana or other forms of cannabis. Yet purified, FDA-approved medicinal preparations of THC are available in pill form… Why not just take a pill? There are several reasons that some patients prefer puffing over swallowing. One quantitatively minor factor is potential lethality.

It is possible to get a fatal overdose by swallowing too many THC pills at once, whereas documented evidence of death simply from smoking too much cannabis does not seem to exist.”

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/

Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis.

“The aims of this study are to assess the therapeutic satisfaction within a group of patients using prescribed pharmaceutical-grade cannabis and to compare the subjective effects among the available strains with special focus on their delta-9-tetrahydrocannabinol and cannabidiol content…

One hundred two patients were included; their average age was 53 years and 76% used it for more than a year preceding this study. Chronic pain (53%; n = 54) was the most common medical indication for using cannabis followed by multiple sclerosis (23%; n = 23), and 86% (n = 88) of patients (almost) always experienced therapeutic satisfaction when using pharmaceutical cannabis.

These results show that patients report therapeutic satisfaction with pharmaceutical cannabis, mainly pain alleviation. Some subjective effects were found to differ among the available strains of cannabis, which is discussed in relation to their different tetrahydrocannabinol/cannabidiol content. These results may aid in further research and critical appraisal for medicinally prescribed cannabis products.”

http://www.ncbi.nlm.nih.gov/pubmed/24747979

The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use.

“The state-level legalization of medical marijuana has raised concerns about increased accessibility and appeal of the drug to youth. The objective of this study was to assess the impact of medical marijuana legalization across the United States by comparing trends in adolescent marijuana use between states with and without legalization of medical marijuana…

CONCLUSIONS:

This study did not find increases in adolescent marijuana use related to legalization of medical marijuana.”

http://www.ncbi.nlm.nih.gov/pubmed/24742758

“Legalizing medical marijuana doesn’t increase use among adolescents, study says” http://www.sciencedaily.com/releases/2014/04/140423102754.htm#.U1heqwRkPNA.twitter

[Therapeutic use of cannabis derivatives].

“The therapeutic use of cannabis has generated a lot of interest in the past years, leading to a better understanding of its mechanisms of action…

Cannabinoids such as dronabinol, Sativex and nabilone have been tested for the treatment of acute and chronic pain. These agents are most promising to relieve chronic pain associated with cancer, with human immunodeficiency virus infection and with multiple sclerosis…”

http://www.ncbi.nlm.nih.gov/pubmed/24701869

Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids in Humans?

“The aim of this study was to evaluate whether physical exercise or food deprivation may increase cannabionoid levels in serum or urine in abstinent chronic cannabis users.

We conclude that exercise and/or food deprivation are unlikely to cause sufficient cannabinoid concentration changes to hamper correct interpretations in drug testing programmes.”

http://www.ncbi.nlm.nih.gov/pubmed/24674455